Citations

Showing 10 of 107969 citations.

Early Experience of Pre- and Post-Contrast 7.0T MRI in Brain Tumors
Paek, Seung Leal, Chung, Young Seob , Paek, Sun Ha , Hwang, Jae Ha , Sohn, Chul‐Ho , Choi, Seung Hong , Son, Young‐Don , Kim, Young-Bo , Kim, Dong Gyu , Lee, Kendall H. , Cho, Zang‐Hee

Mayo Clinic

Journal of Korean Medical Science | September 2, 2013 | Volume: 28 | Issue: 9 | Pages: 1362

10.3346/jkms.2013.28.9.1362 | PMID 24015044 Get It

Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels
Greenberg, Alexandra J. , Walters, Denise K., Kumar, Shaji , Rajkumar, S. Vincent , Jelinek, Diane F., Rajkumar, S Vincent

Mayo Clinic

European Journal of Haematology | September 2, 2013 | Volume: 91 | Issue: 6 | Pages: 504-513

10.1111/ejh.12192 | PMID 23992230 Get It

AbstractThe introduction of novel immunomodulatory drugs (IMiDs) has dramatically improved the survival of patients with multiple myeloma (MM). While it has been shown that patients with specific cytogenetic subtypes, namely t(4;14), have the best outcomes when treated with bortezomib‐based regimens, the relationship between cytogenetic subtypes and response to IMiDs remains unclear. Using DNA synthesis assays, we investigated the relationship between cytogenetic subtype and lenalidomide response in a representative panel of human myeloma cell lines (HMCLs). We examined HMCL protein expression levels of the lenalidomide target cereblon (CRBN) and its downstream target interferon regulatory factor‐4 (IRF4), which have previously been shown to be predictive of lenalidomide response in HMCLs. Our results reveal that lenalidomide response did not correlate with specific cytogenetic translocations. There were distinct groups of lenalidomide‐responsive and non‐responsive HMCLs, as defined by inhibition of cellular proliferation; notably, all of the hyperdiploid HMCLs fell into the latter category. Repeated dosing of lenalidomide significantly lowered the IC50 of the responsive HMCL ALMC‐1 (IC50 = 2.6 μm vs. 0.005 μm, P < 0.0001), but did not have an effect on the IC50 of the non‐responsive DP‐6 HMCL (P > 0.05). Moreover, no association was found between lenalidomide responsiveness and CRBN and IRF4 expression. Our data indicate that lenalidomide sensitivity is independent of cytogenetic subtype in HMCLs. While CRBN and IRF4 have been shown to be associated with response to lenalidomide in patients, these findings do not translate back to HMCLs, which could be attributable to factors present in the bone marrow microenvironment.
OnabotulinumtoxinA therapy for compensatory hyperhidrosis
Adefusika, Jessica A., Brewer, Jerry D.

Mayo Clinic

Journal of Cosmetic Dermatology | September 2, 2013 | Volume: 12 | Issue: 3 | Pages: 232-234

10.1111/jocd.12049 | PMID 23992165 Get It

SummaryBackgroundCompensatory hyperhidrosis due to the treatment for focal primary hyperhidrosis can be devastating and life‐altering.ObjectiveThe purpose of this paper is to discuss use of the iodine starch test and dilute botulinum toxin to decrease compensatory hyperhidrosis over large surface areas.MethodsA large area of the trunk affected by compensatory hyperhidrosis was treated with dilute botulinum toxin therapy using a starch iodine test for localization.ResultsThe patient had exceptional results with his compensatory truncal sweating returning to normal and remaining stable for multiple months.ConclusionTreating compensatory hyperhidrosis of large surface areas with dilute botulinum toxin therapy is effective and safe.
Update on positron emission tomography for imaging of prostate cancer
Kitajima, Kazuhiro , Nathan, Mark A., Sugimura, Kazuro , Murphy, Robert C.

Mayo Clinic

International Journal of Urology | September 2, 2013 | Volume: 21 | Issue: 1 | Pages: 12-23

10.1111/iju.12250 | PMID 23991644 Get It

AbstractProstate cancer is the most common non‐cutaneous malignancy among men in the Western world, and continues to be a major health problem. Imaging has recently become more important in the clinical management of prostate cancer patients, including diagnosis, staging, choice of optimal treatment strategy, treatment follow up and restaging. Positron emission tomography, a functional and molecular imaging technique, has opened a new field in clinical oncological imaging. The most common positron emission tomography radiotracer, 18F‐fluorodeoxyglucose, has been limited in imaging of prostate cancer. Recently, however, other positron emission tomography tracers, such as 11C‐acetate and 11C‐ or 18F‐choline, have shown promising results. In the present review article, we overview the potential and current use of positron emission tomography or positron emission tomography/computed tomography imaging employing the four most commonly used positron emission tomography radiotracers, 18F‐fluorodeoxyglucose, 11C‐acetate and 11C‐ or 18F‐choline, for imaging evaluation of prostate cancer.
Masked polycythemia Vera (mPV): Results of an international study
Barbui, Tiziano , Thiele, Jürgen, Gisslinger, Heinz , Carobbio, Alessandra , Rumi, Elisa , Randi, Maria Luigia , Betozzi, Irene, Pieri, Lisa , Carrai, Valentina , Gisslinger, Bettina, Müllauer, Leonhard , Ruggeri, Marco , Rambaldi, Alessandro , Tefferi, Ayalew , Finazzi, Guido , Vannucchi, Alessandro M. , Rambaldi, Alessandro

Mayo Clinic

American Journal of Hematology | August 31, 2013 | Volume: 89 | Issue: 1 | Pages: 52-54

10.1002/ajh.23585 | PMID 23996471 Get It

We examined the baseline features and clinical outcomes of 140 patients presenting with JAK2V617F positivity and a bone marrow morphology conforming with WHO criteria of polycythemia vera (PV), but a hemoglobin level of <18.5 g/dL in males (range 16.0–18.4) and <16.5 g/dL in females (range 15.0–16.4). This cohort operationally referred to as masked PV (mPV) was compared with 257 patients with overt PV and displayed male predominance, a more frequent history of arterial thrombosis and thrombocytosis. Incidence of thrombosis was similar between the two groups but mPV displayed significantly higher rates of progression to myelofibrosis and acute leukemia and inferior survival. In multivariable analysis mPV diagnosis was an independent predictor of poor survival along with age >65 years and leukocyte count >10 × 109/L. Our data suggest that mPV is a heterogeneous myeloproliferative neoplasia and not necessarily an early/ pre‐polycythemic form of classical PV that at onset in a small fraction of patients clinically may mimic essential thrombocythemia. On the other hand, the majority mPV may have a longer prodrome of undiagnosed PV or a disease biology akin to primary myelofibrosis‐post PV myelofibrosis that could explain the worsening of outcome in comparison to overt/classical manifestations. Am. J. Hematol. 89:52–54, 2014. © 2013 Wiley Periodicals, Inc.
Ultrasound‐guided Ischial Bursa Injection: Technique and Positioning Considerations
Wisniewski, Steve J. , Hurdle, Mark Friedrich B., Erickson, Jason M., Smith, Jay , Hurdle, Mark, Finnoff, Jonathan T.

Mayo Clinic

PM&R | August 31, 2013 | Volume: 6 | Issue: 1 | Pages: 56-60

10.1016/j.pmrj.2013.08.603 | PMID 24001885 Get It

ObjectivesTo 1) describe and validate an ultrasound‐guided ischial bursa injection technique in an unembalmed cadaveric model and 2) to compare the distance between the ischial tuberosity and the sciatic nerve in a hip neutral versus 90° flexed hip position in asymptomatic volunteers.DesignThe first part was a single‐blind prospective study. The second part was a prospective cohort study.SettingAn academic institution procedural skills laboratory and outpatient clinic.ParticipantsThe first part of the study involved 1 cadaveric specimen. The second part of the study involved 20 asymptomatic subjects. The mean age of the subjects was 28 years, and the mean (standard deviation) body mass index was 23.2 ± 2.8 kg/m2 (minimum, 18.3 kg/m2; maximum, 29.5 kg/m2).MethodsIn the first part of the study, a single operator completed bilateral ultrasound‐guided ischial bursa injections in an unembalmed cadaveric specimen by using diluted colored latex. In the second part of the study, ultrasound was used in 20 asymptomatic volunteer subjects (10 men and 10 women) to measure the distance from the lateral edge of the ischial tuberosity to the sciatic nerve.Main Outcome MeasurementsThe injections were graded for accuracy as follows: accurate (all injectate contained within the ischial bursa), accurate with overflow (injectate within the ischial bursa but also located in adjacent structures other than the needle track), or inaccurate (injectate not within the ischial bursa). The second part of the study measured the distance from the ischial tuberosity to the sciatic nerve with subjects in 2 different positions (prone and side lying with the tested hip flexed to 90°).ResultsPostinjection cadaveric dissections revealed that both ultrasound‐guided injections accurately placed liquid latex within the ischial bursae. There was no evidence of injury to surrounding neurovascular structures. Among asymptomatic volunteers, the average distance between the ischial tuberosity and the sciatic nerve increased from 28.4 mm (range, 20.5‐38.9 mm) in the neutral position to 41.9 mm (range, 30.9‐66.0 mm) with the hip flexed to 90° (average change, 13.5 mm away from the ischial tuberosity; P = .0001).ConclusionsUltrasound‐guided ischial bursa injections are technically feasible. Flexing the hip to 90° increases the distance between the ischial tuberosity and the sciatic nerve in asymptomatic volunteers, thus potentially resulting in a safer needle trajectory when ischial bursa injections are clinically indicated. Further investigation in clinical settings is warranted to validate these findings.
Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice
Roos, Carolyn M, Hagler, Michael A , Zhang, Bin , Oehler, Elise A., Miller, Jordan D. , Arghami, Arman , Miller, Jordan

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | August 31, 2013 | Volume: 305 | Issue: 10 | Pages: H1428-H1439

10.1152/ajpheart.00735.2012 | PMID 23997094 Get It

The purpose of this study was to characterize changes in antioxidant and age-related gene expression in aorta and aortic valve with aging, and test the hypothesis that increased mitochondrial oxidative stress accelerates age-related endothelial and aortic valve dysfunction. Wild-type (MnSOD+/+) and manganese SOD heterozygous haploinsufficient (MnSOD+/−) mice were studied at 3 and 18 mo of age. In aorta from wild-type mice, antioxidant expression was preserved, although there were age-associated increases in Nox2 expression. Haploinsufficiency of MnSOD did not alter antioxidant expression in aorta, but increased expression of Nox2. When compared with that of aorta, age-associated reductions in antioxidant expression were larger in aortic valves from wild-type and MnSOD haploinsufficient mice, although Nox2 expression was unchanged. Similarly, sirtuin expression was relatively well-preserved in aorta from both genotypes, whereas expression of SIRT1, SIRT2, SIRT3, SIRT4, and SIRT6 were significantly reduced in the aortic valve. Expression of p16ink4a, a marker of cellular senescence, was profoundly increased in both aorta and aortic valve from MnSOD+/+ and MnSOD+/− mice. Functionally, we observed comparable age-associated reductions in endothelial function in aorta from both MnSOD+/+ and MnSOD+/− mice. Interestingly, inhibition of NAD(P)H oxidase with apocynin or gp91ds-tat improved endothelial function in MnSOD+/+ mice but significantly impaired endothelial function in MnSOD+/− mice at both ages. Aortic valve function was not impaired by aging or MnSOD haploinsufficiency. Changes in antioxidant and sirtuin gene expression with aging differ dramatically between aorta and aortic valve. Furthermore, although MnSOD does not result in overt cardiovascular dysfunction with aging, compensatory transcriptional responses to MnSOD deficiency appear to be tissue specific.
Biophysical determinants of alveolar epithelial plasma membrane wounding associated with mechanical ventilation
Hussein, Omar , Walters, Bruce J., Stroetz, Randolph W., Valencia, Paul, McCall, Deborah, Hubmayr, Rolf D.

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 30, 2013 | Volume: 305 | Issue: 7 | Pages: L478-L484

10.1152/ajplung.00437.2012 | PMID 23997173 Get It

Mechanical ventilation may cause harm by straining lungs at a time they are particularly prone to injury from deforming stress. The objective of this study was to define the relative contributions of alveolar overdistension and cyclic recruitment and “collapse” of unstable lung units to membrane wounding of alveolar epithelial cells. We measured the interactive effects of tidal volume (V T ), transpulmonary pressure (P TP ), and of airspace liquid on the number of alveolar epithelial cells with plasma membrane wounds in ex vivo mechanically ventilated rat lungs. Plasma membrane integrity was assessed by propidium iodide (PI) exclusion in confocal images of subpleural alveoli. Cyclic inflations of normal lungs from zero end-expiratory pressure to 40 cmH 2 O produced V T values of 56.9 ± 3.1 ml/kg and were associated with 0.12 ± 0.12 PI-positive cells/alveolus. A preceding tracheal instillation of normal saline (3 ml) reduced V T to 49.1 ± 6 ml/kg but was associated with a significantly greater number of wounded alveolar epithelial cells (0.52 ± 0.16 cells/alveolus; P < 0.01). Mechanical ventilation of completely saline-filled lungs with saline (V T = 52 ml/kg) to pressures between 10 and 15 cmH 2 O was associated with the least number of wounded epithelial cells (0.02 ± 0.02 cells/alveolus; P < 0.01). In mechanically ventilated, partially saline-filled lungs, the number of wounded cells increased substantially with V T , but, once V T was accounted for, wounding was independent of maximal P TP . We found that interfacial stress associated with the generation and destruction of liquid bridges in airspaces is the primary biophysical cell injury mechanism in mechanically ventilated lungs.
Inflammatory “Cap” Polyposis
Petris, Giovanni De , Dhungel, Bal M. , Pasha, Shabana F., De Petris, Giovanni, Chen, Longwen

Mayo Clinic

International Journal of Surgical Pathology | August 30, 2013 | Volume: 22 | Issue: 4 | Pages: 378-382

10.1177/1066896913501383 | PMID 23994878 Get It

Inflammatory cap polyposis (ICP) is a rare nonneoplastic polyposis of the colon of unknown etiology that can be confused with prolapse-induced polyps and hyperplastic polyposis. We contribute a case of ICP from a 59-year-old woman who was affected by severe constipation and hematochezia. Numerous sessile and semipedunculated polyps were found in the colon, all with cap of whitish fibrin. Histology revealed erosion of the surface, superficial dilated crypts filled with mucoid inflammatory exudate, and minimal crypt serration, all findings typical of ICP. Only the largest polyps had smooth muscle in the mucosa. Ki-67 showed modest expansion and irregular distribution of the crypts proliferative areas. Low-degree positivity for p16, similar to that of hyperplastic polyps, was found. CK20 was expressed as in normal mucosa. Distinguishing between ICP and other polyposis is important because of difference in management.